Prognostic value of aspartate aminotransferase to platelet ratio index as a noninvasive biomarker in patients with hepatocellular carcinoma: a meta-analysis

References

• FornerALlovetJMBruixJHepatocellular carcinomaLancet201237998221245125522353262
   PubMed Web of Science ®Google Scholar
• MaluccioMCoveyARecent progress in understanding, diagnosing, and treating hepatocellular carcinomaCA Cancer J Clin201262639439923070690
   PubMed Web of Science ®Google Scholar
• TangAHallouchOChernyakVKamayaASirlinCBEpidemiology of hepatocellular carcinoma: target population for surveillance and diagnosisAbdom Radiol20184311325
   PubMed Web of Science ®Google Scholar
• ZhangJLinHWangXYPredictive value of microRNA-143 in evaluating the prognosis of patients with hepatocellular carcinomaCancer Biomark201719325726228436387
   PubMed Web of Science ®Google Scholar
• YangXPZhouLXYangQJDiagnostic and prognostic roles of serum vitronectin in hepatitis B-related hepatocellular carcinomaCancer Biomark201617327127927802203
   PubMed Web of Science ®Google Scholar
• ChenCJGlobal elimination of viral hepatitis and hepatocellular carcinoma: opportunities and challengesGut201867459559829367206
   PubMed Web of Science ®Google Scholar
• WangYAttarBMFuentesHEJaiswalPTafurAJEvaluation of the prognostic value of platelet to lymphocyte ratio in patients with hepa-tocellular carcinomaJ Gastrointest Oncol2017861065107129299368
   PubMed Web of Science ®Google Scholar
• ZhaoTCuiLLiAThe significance of RDW in patients with hepatocellular carcinoma after radical resectionCancer Biomark201616450751227062565
   PubMed Web of Science ®Google Scholar
• NishijimaTFMussHBShacharSSTamuraKTakamatsuYPrognostic value of lymphocyte-to-monocyte ratio in patients with solid tumors: A systematic review and meta-analysisCancer Treat Rev2015411097197826481060
   PubMed Web of Science ®Google Scholar
• LinHJiaoXYuBClinical significance of serum 14-3-3 beta in patients with hepatocellular carcinomaCancer Biomark201720214315028869445
   PubMed Web of Science ®Google Scholar
• HungHHSuCWLaiCRFibrosis and AST to platelet ratio index predict post-operative prognosis for solitary small hepatitis B-related hepatocellular carcinomaHepatol Int20104469169921286339
   PubMed Web of Science ®Google Scholar
• KaoWYChiouYYHungHHRisk factors for long-term prognosis in hepatocellular carcinoma after radiofrequency ablation therapy: the clinical implication of aspartate aminotransferase-platelet ratio indexEur J Gastroenterol Hepatol201123652853621537128
   PubMed Web of Science ®Google Scholar
• ShenSLFuSJChenBPreoperative aspartate aminotransfer-ase to platelet ratio is an independent prognostic factor for hepatitis B-induced hepatocellular carcinoma after hepatic resectionAnn Surg Oncol201421123802380924849520
   PubMed Web of Science ®Google Scholar
• PangQZhangJYXuXSThe prognostic values of 12 cirrhosis-relative noninvasive models in patients with hepatocellular carcinomaScand J Clin Lab Invest2015751738425465804
   PubMed Web of Science ®Google Scholar
• PangQZhangJYXuXSSignificance of platelet count and platelet-based models for hepatocellular carcinoma recurrenceWorld J Gastroenterol201521185607562125987786
   PubMed Web of Science ®Google Scholar
• OkamuraYAshidaRYamamotoYThe FIB-4 index is a significant prognostic factor in patients with non-B non-C hepatocellular carcinoma after curative surgeryLangenbecks Arch Surg2016401219520326943655
   PubMed Web of Science ®Google Scholar
• ChungHAKimJHHwangYNoninvasive fibrosis marker can predict recurrence of hepatocellular carcinoma after radiofrequency ablationSaudi J Gastroenterol2016221576326831608
   PubMed Web of Science ®Google Scholar
• JiFLiangYFuSJA novel and accurate predictor of survival for patients with hepatocellular carcinoma after surgical resection: the neutrophil to lymphocyte ratio (NLR) combined with the aspartate amino-transferase/platelet count ratio index (APRI)BMC Cancer20161613726907597
   PubMed Web of Science ®Google Scholar
• LiuYWangZXCaoYPreoperative inflammation-based markers predict early and late recurrence of hepatocellular carcinoma after curative hepatectomyHepatobiliary Pancreat Dis Int201615326627427298102
   PubMed Web of Science ®Google Scholar
• PengWLiCWenTFPostoperative aspartate aminotransferase to platelet ratio index change predicts prognosis for hepatocellular carcinomaMedicine20169530e416027472685
   PubMed Web of Science ®Google Scholar
• TengWHsiehYCLuiKWEradication of hepatitis C virus profoundly prolongs survival in hepatocellular carcinoma patients receiving transarterial chemoembolizationJ Viral Hepat201724121160116728643457
   PubMed Web of Science ®Google Scholar
• ToyodaHKumadaTTadaTDifferences in the impact of prognostic factors for hepatocellular carcinoma over timeCancer Sci2017108122438244428945309
   PubMed Web of Science ®Google Scholar
• SarkarJDeleonTWongLLMELD score and AST-to-platelet ratio index (APRI) predict long-term survival in patients with a small hepa-tocellular carcinoma following non-transplant therapies: a pilot studyHepatoma Res20173798529075672
   PubMedGoogle Scholar
• YangHJJiangJHYangYTStratified aspartate aminotransferase-to-platelet ratio index accurately predicts survival in hepatocellular carcinoma patients undergoing curative liver resectionTumour Biol2017393 1010428317695944
   Google Scholar
• TangTQiuJLLiGWAspartate aminotransferase-to-platelet ratio predicts response to transarterial chemoembolisation and prognosis in hepatocellular carcinoma patientsClin Radiol201873325926529032942
   PubMed Web of Science ®Google Scholar
• WaiCTChengCLWeeANon-invasive models for predicting histology in patients with chronic hepatitis BLiver Int200626666667216842322
   PubMed Web of Science ®Google Scholar
• BaranovaALalPBirerdincAYounossiZMNon-invasive markers for hepatic fibrosisBMC Gastroenterol2011119121849046
   PubMed Web of Science ®Google Scholar
• ShaheenAAMyersRPDiagnostic accuracy of the aspartate amino-transferase-to-platelet ratio index for the prediction of hepatitis C-related fibrosis: a systematic reviewHepatology200746391292117705266
   PubMed Web of Science ®Google Scholar
• ElsebaeMMAbu-ZekriNBA study of the effect of splenectomy on hepatic functional reserve and structural damage in patients with chronic hepatitis C virus infection by non-invasive serum markers. A prospective studyInt J Surg20086536236618662898
   PubMedGoogle Scholar
• ChenSLXueNWuMTInfluence of preoperative serum aspartate aminotransferase (AST) level on the prognosis of patients with non-small cell lung cancerInt J Mol Sci2016179 pii:E1474
   Web of Science ®Google Scholar
• WanGGaoFChenJNomogram prediction of individual prognosis of patients with hepatocellular carcinomaBMC Cancer20171719128143427
   PubMed Web of Science ®Google Scholar
• KamimotoYHoriuchiSTanaseSMorinoYPlasma clearance of intravenously injected aspartate aminotransferase isozymes: evidence for preferential uptake by sinusoidal liver cellsHepatology1985533673753997068
   PubMed Web of Science ®Google Scholar
• KumadaTToyodaHKiriyamaSPredictive value of tumor markers for hepatocarcinogenesis in patients with hepatitis C virusJ Gastroenterol2011464e44
   Web of Science ®Google Scholar
• KimHCNamCMJeeSHNormal serum aminotransferase concentration and risk of mortality from liver diseases: prospective cohort studyBr Med J2004328744698315028636
   PubMed Web of Science ®Google Scholar
• ToghillPJGreenSFergusonFPlatelet dynamics in chronic liver disease with special reference to the role of the spleenJ Clin Pathol1977304367371853132
   PubMed Web of Science ®Google Scholar
• MccormickPAMurphyKMSplenomegaly, hypersplenism and coagulation abnormalities in liver diseaseBaillieres Best Pract Res Clin Gastroenterol20001461009103111139352
   PubMed Web of Science ®Google Scholar
• TomimaruYEguchiHGotohKPlatelet count is more useful for predicting posthepatectomy liver failure at surgery for hepatocel-lular carcinoma than indocyanine green clearance testJ Surg Oncol2016113556556926751258
   PubMed Web of Science ®Google Scholar
• MaithelSKKneuertzPJKoobyDAImportance of low preoperative platelet count in selecting patients for resection of hepa-tocellular carcinoma: a multi-institutional analysisJ Am Coll Surg20112124638648 discussion 648–65021463803
   PubMed Web of Science ®Google Scholar